10 June 2025. The newly identified SARS-CoV-2 variant, NB.1.8.1, is an
Omicron-descendent lineage derived from the recombinant variant XDV.1.5.1.
Preliminary data indicate that the NB.1.8.1 variant has mutations in the spike
protein that may increase the variant’s transmissibility and that result in marginal
immune evasion compared to other currently circulating variants.